Meritage Portfolio Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.48M | Sell |
61,020
-14,783
| -20% | -$1.57M | 0.41% | 65 |
|
2025
Q1 | $9.41M | Buy |
75,803
+9,529
| +14% | +$1.18M | 0.62% | 40 |
|
2024
Q4 | $8.16M | Sell |
66,274
-14,333
| -18% | -$1.77M | 0.51% | 50 |
|
2024
Q3 | $8.98M | Sell |
80,607
-771
| -0.9% | -$85.9K | 0.55% | 40 |
|
2024
Q2 | $8.69M | Sell |
81,378
-1,159
| -1% | -$124K | 0.55% | 42 |
|
2024
Q1 | $9.94M | Sell |
82,537
-2,502
| -3% | -$301K | 0.63% | 34 |
|
2023
Q4 | $10.5M | Buy |
85,039
+4,727
| +6% | +$581K | 0.69% | 29 |
|
2023
Q3 | $10.4M | Buy |
80,312
+2,331
| +3% | +$302K | 0.77% | 26 |
|
2023
Q2 | $9.67M | Sell |
77,981
-7,289
| -9% | -$904K | 0.68% | 30 |
|
2023
Q1 | $12.5M | Buy |
85,270
+34,987
| +70% | +$5.12M | 0.93% | 20 |
|
2022
Q4 | $8.01M | Buy |
+50,283
| New | +$8.01M | 0.63% | 39 |
|
2018
Q3 | – | Sell |
-33,564
| Closed | -$5.78M | – | 203 |
|
2018
Q2 | $5.78M | Sell |
33,564
-248
| -0.7% | -$42.7K | 0.56% | 61 |
|
2018
Q1 | $5.11M | Buy |
+33,812
| New | +$5.11M | 0.49% | 83 |
|
2016
Q4 | – | Sell |
-30,225
| Closed | -$3.67M | – | 193 |
|
2016
Q3 | $3.67M | Sell |
30,225
-23
| -0.1% | -$2.79K | 0.4% | 127 |
|
2016
Q2 | $4.27M | Buy |
+30,248
| New | +$4.27M | 0.48% | 107 |
|